CBIZ Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $2.28 |
| EPS actual | $2.50 |
| EPS Surprise | 9.65% |
| Revenue estimate | 853.46M |
| Revenue actual | 848.579M |
| Revenue Surprise | -0.572% |
| Release date | Feb 25, 2026 |
| EPS estimate | -$0.660 |
| EPS actual | -$0.700 |
| EPS Surprise | -6.06% |
| Revenue estimate | 578.033M |
| Revenue actual | 542.663M |
| Revenue Surprise | -6.12% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.94 |
| EPS actual | $1.01 |
| EPS Surprise | 7.45% |
| Revenue estimate | 578.019M |
| Revenue actual | 693.818M |
| Revenue Surprise | 20.03% |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.84 |
| EPS actual | $0.95 |
| EPS Surprise | 13.10% |
| Revenue estimate | 726.851M |
| Revenue actual | 683.496M |
| Revenue Surprise | -5.96% |
Last 4 Quarters for CBIZ
Below you can see how CBZ performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $76.15 |
| EPS estimate | $0.84 |
| EPS actual | $0.95 |
| EPS surprise | 13.10% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $76.56 |
| Jul 25, 2025 | $77.81 |
| Jul 28, 2025 | $76.75 |
| Jul 29, 2025 | $75.72 |
| Jul 30, 2025 | $76.15 |
| Jul 31, 2025 | $61.12 |
| Aug 01, 2025 | $61.75 |
| Aug 04, 2025 | $63.26 |
| Aug 05, 2025 | $62.68 |
| 4 days before | -0.536% |
| 4 days after | -17.69% |
| On release day | -19.74% |
| Change in period | -18.13% |
| Release date | Oct 29, 2025 |
| Price on release | $51.31 |
| EPS estimate | $0.94 |
| EPS actual | $1.01 |
| EPS surprise | 7.45% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $53.20 |
| Oct 24, 2025 | $53.29 |
| Oct 27, 2025 | $52.77 |
| Oct 28, 2025 | $52.25 |
| Oct 29, 2025 | $51.31 |
| Oct 30, 2025 | $52.92 |
| Oct 31, 2025 | $55.00 |
| Nov 03, 2025 | $55.09 |
| Nov 04, 2025 | $55.06 |
| 4 days before | -3.55% |
| 4 days after | 7.31% |
| On release day | 3.14% |
| Change in period | 3.50% |
| Release date | Feb 25, 2026 |
| Price on release | $27.28 |
| EPS estimate | -$0.660 |
| EPS actual | -$0.700 |
| EPS surprise | -6.06% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $29.88 |
| Feb 20, 2026 | $29.15 |
| Feb 23, 2026 | $27.68 |
| Feb 24, 2026 | $27.78 |
| Feb 25, 2026 | $27.28 |
| Feb 26, 2026 | $31.80 |
| Feb 27, 2026 | $28.64 |
| Mar 02, 2026 | $28.80 |
| Mar 03, 2026 | $29.86 |
| 4 days before | -8.70% |
| 4 days after | 9.46% |
| On release day | 16.57% |
| Change in period | -0.0669% |
| Release date | Apr 29, 2026 |
| Price on release | $33.17 |
| EPS estimate | $2.28 |
| EPS actual | $2.50 |
| EPS surprise | 9.65% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $29.71 |
| Apr 24, 2026 | $30.67 |
| Apr 27, 2026 | $30.66 |
| Apr 28, 2026 | $32.48 |
| Apr 29, 2026 | $33.17 |
| Apr 30, 2026 | $30.50 |
| May 01, 2026 | $32.13 |
| May 04, 2026 | $32.25 |
| May 05, 2026 | $31.30 |
| 4 days before | 11.65% |
| 4 days after | -5.64% |
| On release day | -8.05% |
| Change in period | 5.35% |
CBIZ Earnings Call Transcript Summary of Q1 2026
Q1 2026 highlights: CBIZ reported results largely in line with expectations — consolidated revenue $849M (+1.3% y/y), organic revenue +1.0%, adjusted EBITDA $244M (up $3M y/y), and adjusted diluted EPS $2.50 (+7% y/y). Free cash flow improved materially (helped by a one-time $53M purchase-price adjustment) and supported ~ $63M of share repurchases through April; net leverage fell to ~3.4x. Management reaffirmed 2026 guidance: revenue $2.8B–$2.9B (2%–5% growth), adjusted EBITDA $465M–$475M, free cash flow $270M–$290M, and increased adjusted EPS to $4.00–$4.10 reflecting lower share count from buybacks. Organic growth improved sequentially during Q1 and management expects to exit the year at a mid-single-digit organic growth rate as integration-related headwinds abate in H2. Strategic priorities: (1) talent attraction and lateral hires (B&I producers target ~15% growth), (2) national brand campaign and industry verticals to drive cross-selling, (3) AI investments — moving from assistive to agentic AI with early efficiency gains (example: 20% efficiency in year 1 for an attest workflow, with potential to reach 40%), and (4) offshoring expansion (targeting ~10% offshore hours in 2026 and >20% over several years). Capital allocation: continue to fund organic growth and maintenance capex, prioritize deleveraging (target <2.5x net leverage in 2027), and opportunistic share repurchases at current valuations. Management emphasized the durability of recurring revenue, improving pipeline for advisory work, and the belief that AI and scale create a competitive moat and margin expansion opportunities.
Sign In
Buy CBZ